Clinical findings of the phakomatoses: SturgeWeber syndrome
Mark Quigg, MD, MSc,
Robert S. Rust, MD and
James Q. Miller, MD
From the Department of Neurology, University of Virginia, Charlottesville.
Address correspondence and reprint requests to Dr. Mark Quigg, Department of Neurology, Box 800394, Health Sciences Center, University of Virginia, Charlottesville, VA 22908; e-mail: quigg{at}virginia.edu
The dermatologic hallmark of SturgeWeber syndrome (SWS)is the nevus flammeus (port-wine stain, PWS), a angiomatouslesion usually distributed in the region innervated by the ophthalmicbranch of the trigeminal nerve1 caused by lack of normal regressionof embryonic vascular plexus of the cephalic neural tube. Thevariable constellation of clinical findings of hemiparesis,mental retardation, and epilepsy is caused by the resultingleptomeningeal and cortical angiomatosis and calcification.SWS is a congenital and nonhereditary disorder. Physical findingsof SWS are shown in figure 1 and neuroimaging in figure 2.
Figure 1. (A) Ophthalmic port-wine stain (PWS) in an infant. Glaucoma is a frequent complication. PWS that spares ophthalmic trigeminal distribution is usually not indicative of underlying SturgeWeber syndrome.1(B) Bilateral or more lower facial involvement occurs in 15%.1As in this child, about half have an extracranial nevus that typically respects segmental anatomy.
Figure 2. (A) A-P skull film that demonstrates the gyral calcifications of the subarachnoid angiomas of SturgeWeber syndrome, tortuous parallel "tram tracks" across most of the right hemisphere. (B) In another patient, uncontrasted axial CT and (C) gradient-echo axial MRI show gyral calcifications, atrophy, and gliosis of the underlying cortex due to leptomeningeal involvement.
Acknowledgment
The authors thank C. Douglas Phillips of the Division of Neuroradiologyfor his contributions of MRI images.
Footnotes
Deceased.
Disclosure: The authors report no conflicts of interest.
Reference
Tallman B, Tan OT, Morelli JG, et al. Location of port-wine stains and the likelihood of ophthalmic and/or central nervous system complications. Pediatrics 1991;87:323327.[Abstract/Free Full Text]